Retatrutide 30 mg

RT-2026-011Lot IP261006Analyzed October 13, 2026

Timeline

Ordered

October 9, 2026

Received

October 12, 2026

Analyzed

October 13, 2026

Sample

Name

Retatrutide 30 mg

Expected

Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

Investigate Peptides

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

31.87mg

Label claim: 30 mg

Purity, how clean it is

>99%

by HPLC-UV peak area

Chromatogram

HPLC-UV

18.47 min, Retatrutide, >99%

Analyst Comments

White lyophilized powder, red-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 13, 2026

Verification Code

RT-GRA8-H3Q5

Verify at purilab.org/verify/RT-GRA8-H3Q5

Scan to Verify

RT-GRA8-H3Q5

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1